This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Stallergenes. Active years: 2016-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2020
Title: The Innovative Mind of Alain Razafindratsita
Introduction
Alain Razafindratsita is an accomplished inventor based in Antony, France. With a noteworthy portfolio containing three patents, he has made significant contributions to the fields of immunology and medical science. His innovative work consistently seeks to improve patient care through advanced therapeutic compositions.
Latest Patents
Razafindratsita's most recent patents focus on compositions for antigen-specific induction of tolerance. These groundbreaking inventions relate to immunogenic compositions designed for sublingual, perlingual, or oral administration. They comprise an antigen and an adjuvant, selected from various lactic acid bacteria or a combination of corticosteroids with vitamin D3 or its metabolites. The inventive aspect of these compositions lies in their ability to elicit antigen-specific immune tolerance, potentially revolutionizing treatment protocols for various immunological conditions.
Career Highlights
Throughout his career, Alain Razafindratsita has been affiliated with Stallergenes, a company renowned for its advancements in allergy treatment and immunotherapies. His work at the company exemplifies his commitment to developing innovative solutions aimed at enhancing the quality of life for patients suffering from allergic diseases. His portfolio reflects a focused dedication to immunology, which has implications for how allergies and autoimmune disorders are managed.
Collaborations
Alain collaborates with notable experts in his field, including Philippe Moingeon and Laurence Van Overtvelt. These partnerships enhance his research and development endeavors, fostering a collaborative environment that promotes innovation. Together, they contribute to the greater scientific community, emphasizing the importance of teamwork in the pursuit of groundbreaking medical advancements.
Conclusion
Alain Razafindratsita's contributions through his inventive spirit and commitment to science are commendable. With a strong focus on antigen-specific immune tolerance, his patents signify crucial steps towards more effective treatment methodologies in immunology. As he continues his work at Stallergenes, the potential for future innovations remains vast, promising a progressive impact on the healthcare landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile